Table 1 Clinical and pathologic details for the patients in the case and control groups
From: Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer
# | Age (years) | Histologic subtype | FIGO stage | FIGO gr. | Nuc. Grd. | LVI | Adjuvant treatment | Outcome | Cyto dx |
|---|---|---|---|---|---|---|---|---|---|
Case group | |||||||||
1 | 76 | Endometrioid | Stage IB → IIIA | 3 | 3 | Yes | EBRT/vaginal brachytherapy | NERM 74 Months | Positive |
2 | 73 | Endometrioid | Stage IB → IIIA | 2 | 2 | No | Vaginal brachytherapy | NERM 61 Months | ATYP |
3 | 59 | Endometrioid | Stage IA → IIIA | 1 | 1 | No | Progestin therapy | NERM 48 Months | Positive |
4 | 72 | Endometrioid | Stage IA → IIIA | 3 | 3 | Yes | Chemotherapy | NERM 55 Months | Positive |
5 | 45 | Endometrioid | Stage IA → IIIA | 1 | 1 | No | No further treatment | NERM 47 Months | ATYP |
6 | 45 | Endometrioid | Stage IA → IIIA | 1 | 1 | No | Chemotherapya | NERM 49 Months | SUSP |
7 | 53 | Endometrioid | Stage IB → IIIA | 3 | 3 | No | Chemotherapya | NERM 94 Months | Positive |
8 | 73 | Endometrioid | Stage IB → IIIA | 1 | 2 | No | Vaginal brachytherapy | NERM 47 Months | Positive |
9 | 69 | MMMT/Serous | Stage IIB → IIIA | NA | 3 | Yes | Chemotherapy/EBRT | NERM 6 Months | Positive |
10 | 79 | Serous | Stage IA → IIIA | NA | 3 | No | Chemotherapy/vaginal brachytherapy | NERM 52 Months | Positive |
Control group | |||||||||
1 | 76 | Endometrioid | Stage IB | 2 | 1 | No | Vaginal brachytherapy | NERM 68 Months | Negative |
2 | 72 | Endometrioid | Stage IA | 1 | 1 | No | No further treatment | NERM 33 Months | Negative |
3 | 73 | Endometrioid | Stage IC | 2 | 2 | No | Vaginal brachytherapy | NERM 63 Months | Negative |
4 | 74 | Endometrioid | Stage IB | 1 | 2 | Yes | Vaginal brachytherapy | NERM 39 Months | Negative |
5 | 60 | Endometrioid | Stage IB | 1 | 2 | Yes | Vaginal brachytherapy | NERM 57 Months | Negative |
6 | 56 | Endometrioid | Stage IA | 1 | 1 | No | No further treatment | NERM 4 Months | Negative |
7 | 73 | Endometrioid | Stage IA | 1 | 1 | No | No further treatment | NERM 60 Months | Negative |
8 | 75 | Endometrioid | Stage IC | 2 | 2 | Yes | EBRT | NERM 106 Months | Negative |
9 | 43 | Endometrioid | Stage IB | 2 | 2 | No | Vaginal brachytherapy | NERM 8 Months | Negative |
10 | 43 | Endometrioid | Stage IB | 2 | 2 | No | Vaginal brachytherapy | NERM 107 Months | Negative |
11 | 43 | Endometrioid | Stage IA | 1 | 1 | No | Vaginal brachytherapy | NERM 79 Months | Negative |
12 | 41 | Endometrioid | Stage IA | 1 | 1 | No | No further treatment | NERM 64 Months | Negative |
13 | 56 | Endometrioid | Stage IA | 1 | 1 | No | No further treatment | NERM 17 Months | Negative |
14 | 56 | Endometrioid | Stage IB | 2 | 2 | Yes | EBRT/vaginal brachytherapy | NERM 69 Months | Negative |
15 | 76 | Endometrioid | Stage IC | 1 | 1 | Yes | EBRT/vaginal brachytherapy | Metastases at 24 Months | Negative |
16 | 75 | Endometrioid | Stage IB | 1 | 2 | No | Vaginal brachytherapy | NERM 39 Months | Negative |
17 | 69 | MMMT | Stage IB | 3 | 3 | Yes | Chemotherapy | NERM 74 Months | Negative |
18 | 70 | Serous | Stage IA | NA | 3 | No | Vaginal brachytherapy/chemotherapy | NERM 45 Months | Negative |
19 | 82 | Serous | Stage IB | NA | 3 | No | Vaginal brachytherapy/chemotherapy | NERM 86 Months | Negative |
